Verified ProfileEN

Gan&Lee Pharmaceuticals

Order verification — $199

Manufacturing · Biological Product Manufacturing

Verification dossier

Gan&Lee Pharmaceuticals is a Chinese company based in Beijing. The company operates in the biological product manufacturing sector, within the broader manufacturing industry. Established 1998, the company has been operating for 28 years.

Sinolinks tracks Gan&Lee Pharmaceuticals as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Drug production; drug wholesale; drug import and export; drug retail; road freight transport (excluding hazardous goods); sales of pharmaceutical excipients. Medical research and experimental development; technical services, development, consulting, exchange, transfer, and promotion; goods import and export; technology import and export; sales of Class II medical devices; sales of Class I medical devices; sales of rubber products; manufacturing of rubber products; sales of metal packaging containers and materials; manufacturing of metal packaging containers and materials; sales of packaging materials and products; manufacturing of medical packaging materials.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review